EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review

Subhangi Basu, Motiur Rahaman, Tuphan Kanti Dolai, Praphulla Chandra Shukla, Nishant Chakravorty

Thalassemia Reports · 03.07.2023 · 13 (3) · 179-194

DOI: 10.3390/thalassrep13030017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thalassemia Reports, online erschienen am 03.07.2023. Verfasst von Subhangi Basu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-thalassemia, a congenital genetic hematological disorder characterized by the decrease or absence of β-globin chains, leads to a decrease in levels of Hemoglobin A. The affected individuals can be categorized into two cohorts based on transfusion dependency: transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT). Remarkably, despite the primary pathology lying in β-globin chain depletion, β-thalassemia also exhibits an intriguing association with iron overload. Iron metabolism, a tightly regulated physiological process, reveals a complex interplay in these patients. Over time, both cohorts of β-thalassemic individuals develop iron overload, albeit through distinct mechanisms. Addressing the diverse complications that arise due to iron overload in β-thalassemic patients, the utilization of iron chelators has gained a lot of significance. With varying efficacies, routes of administration, and modes of action, different iron chelators offer unique benefits to patients. In the Indian context, three commercialized iron chelators have emerged, showcasing a high adherence rate to iron chelator-based treatment regimens among β-thalassemic individuals. In this review, we explore the intriguing connection between β-thalassemia and iron overload, shedding light on the intricate mechanisms at play. We delve into the intricacies of iron metabolism, unveiling the distinct pathways leading to iron accumulation in these patients. Additionally, the therapeutic efficacy of different iron chelators in managing iron overload complications is mentioned briefly, along with the guidelines for their usage in India. Through this comprehensive analysis, we aim to deepen our understanding of β-thalassemia and iron overload, paving the way for optimized treatment strategies. Ultimately, our findings provide valuable insights into improving the care and outcomes of individuals affected by β-thalassemia.

Förderung

  • Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India

Zitieren

APA

Basu, S., Rahaman, M., Dolai, T. K., Shukla, P. C., & Chakravorty, N. (2023). Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review. Thalassemia Reports, 13(3), 179-194. https://doi.org/10.3390/thalassrep13030017

Vancouver

Basu S, Rahaman M, Dolai TK, Shukla PC, Chakravorty N. Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review. Thalassemia Reports. 2023;13(3):179-194. doi:10.3390/thalassrep13030017

BibTeX
@article{Basu2023,
  author = {Basu, Subhangi and Rahaman, Motiur and Dolai, Tuphan Kanti and Shukla, Praphulla Chandra and Chakravorty, Nishant},
  title = {Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review},
  journal = {Thalassemia Reports},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {179--194},
  doi = {10.3390/thalassrep13030017}
}
Kostenlos starten →